NATIXIS ADVISORS, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1018331 Boston, MA

Position in NBIX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$5,743,468

-$107,870 QoQ

Shares Held

43,597

+5.7% QoQ

Ownership

0.043%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

NATIXIS ADVISORS, LLC holds $166,492,947 across 17 Drug Manufacturers - Specialty & Generic names. NBIX ranks #7 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HLN	Haleon plc	9,198,299	$92,074,972
2	TEVA	Teva Pharmaceutical Industries Ltd	565,862	$17,043,763
3	PBH	Prestige Consumer Healthcare Inc.	253,753	$15,039,940
4	UTHR	UNITED THERAPEUTICS Corp	15,249	$9,042,352
5	ZTS	Zoetis Inc.	65,865	$7,785,901
6	TAK	Takeda Pharmaceutical Co Ltd	324,034	$6,001,109
7	NBIX	Neurocrine Biosciences Inc This page	43,597	$5,743,468
8	VTRS	Viatris Inc	234,320	$3,165,663

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,743,468	43,597	+5.7%	Shares	Defined	2026-05-13
2025-12-31	$5,851,338	41,256	-3.6%	Shares	Defined	2026-02-10
2025-09-30	$6,006,298	42,786	+17.6%	Shares	Defined	2025-11-13
2025-06-30	$4,574,110	36,392	+9.2%	Shares	Defined	2025-08-13
2025-03-31	$3,684,307	33,312	-0.9%	Shares	Defined	2025-05-08
2024-12-31	$4,586,946	33,604	+14.6%	Shares	Defined	2025-02-10
2024-09-30	$3,379,056	29,327	-16.8%	Shares	Defined	2024-11-06
2024-06-30	$4,854,244	35,260	+11.1%	Shares	Defined	2024-08-01
2024-03-31	$4,376,063	31,729	+6.4%	Shares	Defined	2024-04-25
2023-12-31	$3,930,532	29,831	-1.7%	Shares	Defined	2024-02-06
2023-09-30	$3,413,587	30,343	+22.5%	Shares	Defined	2023-11-13
2023-06-30	$2,335,811	24,770	-54.3%	Shares	Defined	2023-08-15
2023-03-31	$5,491,286	54,251	-11.3%	Shares	Defined	2023-05-11
2022-12-31	$7,308,772	61,192	-13.2%	Shares	Defined	2023-01-27
2022-09-30	$7,483,769	70,462	+5.5%	Shares	Defined	2022-11-14
2022-06-30	$6,511,176	66,795	+10.7%	Shares	Defined	2022-08-12
2022-03-31	$5,657,718	60,349	+118.6%	Shares	Defined	2022-05-12
2021-12-31	$2,350,947	27,603	-32.7%	Shares	Defined	2022-02-08
2021-09-30	$3,934,420	41,022	+16.8%	Shares	Defined	2021-11-15
2021-06-30	$3,419,046	35,132	+3.2%	Shares	Defined	2021-08-12
2021-03-31	$3,310,195	34,038	+12.0%	Shares	Defined	2021-05-05
2020-12-31	$2,912,306	30,384	-10.7%	Shares	Defined	2021-02-12
2020-09-30	$3,270,978	34,016	+126.6%	Shares	Defined	2020-11-12
2020-06-30	$1,831,586	15,013	+3.1%	Shares	Defined	2020-08-11
2020-03-31	$1,260,773	14,567	—	Shares	Defined	2020-04-27
No filing history on record for this holder in this stock.